179 related articles for article (PubMed ID: 38400008)
1. An Engineered M13 Filamentous Nanoparticle as an Antigen Carrier for a Malignant Melanoma Immunotherapeutic Strategy.
Brišar N; Šuster K; Brezar SK; Vidmar R; Fonović M; Cör A
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400008
[TBL] [Abstract][Full Text] [Related]
2. The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses.
Sartorius R; Pisu P; D'Apice L; Pizzella L; Romano C; Cortese G; Giorgini A; Santoni A; Velotti F; De Berardinis P
J Immunol; 2008 Mar; 180(6):3719-28. PubMed ID: 18322177
[TBL] [Abstract][Full Text] [Related]
3. Construction of genetically engineered M13K07 helper phage for simultaneous phage display of gold binding peptide 1 and nuclear matrix protein 22 ScFv antibody.
Fatemi F; Amini SM; Kharrazi S; Rasaee MJ; Mazlomi MA; Asadi-Ghalehni M; Rajabibazl M; Sadroddiny E
Colloids Surf B Biointerfaces; 2017 Nov; 159():770-780. PubMed ID: 28886513
[TBL] [Abstract][Full Text] [Related]
4. Visualization of Engineered M13 Phages Bound to Bacterial Targets by Transmission Electron Microscopy.
Yang Y; Chen IA
Methods Mol Biol; 2024; 2793():175-183. PubMed ID: 38526731
[TBL] [Abstract][Full Text] [Related]
5. Antibodies and Engineered Antibody Fragments against M13 Filamentous Phage to Facilitate Phage-Display-Based Molecular Breeding.
Kiguchi Y; Oyama H; Morita I; Katayama E; Fujita M; Narasaki M; Yokoyama A; Kobayashi N
Biol Pharm Bull; 2018; 41(7):1062-1070. PubMed ID: 29962401
[TBL] [Abstract][Full Text] [Related]
6. Fusion of Hsp70 to Mage-a1 enhances the potency of vaccine-specific immune responses.
Jiang J; Xie D; Zhang W; Xiao G; Wen J
J Transl Med; 2013 Dec; 11():300. PubMed ID: 24314011
[TBL] [Abstract][Full Text] [Related]
7. Engineering of M13 Bacteriophage for Development of Tissue Engineering Materials.
Jin HE; Lee SW
Methods Mol Biol; 2018; 1776():487-502. PubMed ID: 29869262
[TBL] [Abstract][Full Text] [Related]
8. Novel helper phage design: intergenic region affects the assembly of bacteriophages and the size of antibody libraries.
Dueñas M; Borrebaeck CA
FEMS Microbiol Lett; 1995 Jan; 125(2-3):317-21. PubMed ID: 7875580
[TBL] [Abstract][Full Text] [Related]
9. Antigen-Antibody Interaction-Based Self-Healing Capability of Hybrid Hydrogels Composed of Genetically Engineered Filamentous Viruses and Gold Nanoparticles.
Sawada T; Serizawa T
Protein Pept Lett; 2018; 25(1):64-67. PubMed ID: 29237366
[TBL] [Abstract][Full Text] [Related]
10. The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model.
Fang J; Wang G; Yang Q; Song J; Wang Y; Wang L
Vaccine; 2005 Sep; 23(40):4860-6. PubMed ID: 16029917
[TBL] [Abstract][Full Text] [Related]
11. Rapid and reliable ultrasensitive detection of pathogenic H9N2 viruses through virus-binding phage nanofibers decorated with gold nanoparticles.
Hou J; Qian X; Xu Y; Guo Z; Thierry B; Yang CT; Zhou X; Mao C
Biosens Bioelectron; 2023 Oct; 237():115423. PubMed ID: 37311406
[TBL] [Abstract][Full Text] [Related]
12. Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies.
Sartorius R; D'Apice L; Prisco A; De Berardinis P
Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31480551
[TBL] [Abstract][Full Text] [Related]
13. BACTERIOPHAGE M13 MODULATES THE SEPSIS-RELATED INFLAMMATORY RESPONSES AND ORGAN DAMAGE IN A CLP MODEL.
Rahimi A; Soudi S; Vakilian S; Jamshidi-Adegani F; Sadeghizadeh M; Al-Hashmi S
Shock; 2023 Mar; 59(3):493-504. PubMed ID: 36576361
[TBL] [Abstract][Full Text] [Related]
14. A blood circulation-prolonging peptide anchored biomimetic phage-platelet hybrid nanoparticle system for prolonged blood circulation and optimized anti-bacterial performance.
Jin P; Wang L; Sha R; Liu L; Qian J; Ishimwe N; Zhang W; Qian J; Zhang Y; Wen L
Theranostics; 2021; 11(5):2278-2296. PubMed ID: 33500725
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Filamentous Bacteriophages Encapsulated in Biodegradable Polymeric Microparticles for Stimulation of Innate and Adaptive Immune Responses.
Jamaledin R; Sartorius R; Di Natale C; Vecchione R; De Berardinis P; Netti PA
Microorganisms; 2020 Apr; 8(5):. PubMed ID: 32365728
[No Abstract] [Full Text] [Related]
16. Immunological properties of the SLLTEVET epitope of Influenza A virus in multiple display on filamentous M13 phage.
Lotfi Z; Golchin M; Khalili-Yazdi A; Khalili M
Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():76-80. PubMed ID: 31300131
[TBL] [Abstract][Full Text] [Related]
17. M13 bacteriophage as biometric component for orderly assembly of dynamic light scattering immunosensor.
Zhan S; Fang H; Chen Q; Xiong S; Guo Y; Huang T; Li X; Leng Y; Huang X; Xiong Y
Biosens Bioelectron; 2022 Dec; 217():114693. PubMed ID: 36108584
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies against a minor and the major coat proteins of filamentous phage M13: their application in phage display.
Bhardwaj D; Singh SS; Abrol S; Chaudhary VK
J Immunol Methods; 1995 Feb; 179(2):165-75. PubMed ID: 7876566
[TBL] [Abstract][Full Text] [Related]
19. Plaque reduction test: an alternative method to assess specific antibody response to pIII-displayed peptide of filamentous phage M13.
Yang WJ; Shiuan D
J Immunol Methods; 2003 May; 276(1-2):175-83. PubMed ID: 12738371
[TBL] [Abstract][Full Text] [Related]
20. MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma.
Chianese-Bullock KA; Pressley J; Garbee C; Hibbitts S; Murphy C; Yamshchikov G; Petroni GR; Bissonette EA; Neese PY; Grosh WW; Merrill P; Fink R; Woodson EM; Wiernasz CJ; Patterson JW; Slingluff CL
J Immunol; 2005 Mar; 174(5):3080-6. PubMed ID: 15728523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
